To main content

Research group of Medical Biotechnology

We address unmet medical needs using both enzymatic and cell based assays. Our field of expertise range from advanced eucaryotic cell cultures to microorganisms and viruses.

Contact person

We evaluate efficacy and safety of antibiotics, anti-viral compounds, cancer drugs and experimental formulations, and we do process development for biopharmaceuticals. We collaborate with national and international academic groups and industry.

close-ups of cell cultures

Research areas

  • High throughput screening & high content screening
  • Microbial and mammalian bioproduction, bioprocess and strain development
  • Drug discovery
  • Chemical biology
  • Cell biology, molecular biology and chemical biology
  • Enzyme evolution
  • In vitro characterization (RNA-based therapies, drug efficacy, safety, toxicology and biological responses)
  • Nanomedicine characterization
  • Technologies for Immobilization
  • Cellular models for uptake across intestinal barriers
  • Proteomics
  • Virology
  • Immunology

Our approach

  • All our methods are tailored towards understanding biology at a cellular level
  • We have a large instrument park consisting of robotic liquid handling machines and detection instruments 
  • Our instrument park enables us to produce a large amount of high-quality data
  • Generic and applicable knowledge which can be applied within many research areas
  • Research profile addressing important challenges in society and the development of future medicine
  • Tightly coupled to industrial, marine and sustainable biotechnology, nanomedicine and analytical mass spectrometry


Employees in the research group for Medical Biotechnology

Three pcitures of lab working
Photo: Thor Nielsen/SINTEF